Cargando…

COVID-19 vaccine safety monitoring

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	News Item
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907301/ http://dx.doi.org/10.1007/s40278-021-91448-x

Ejemplares similares

EMA's safety monitoring plan for COVID-19 vaccines
Publicado: (2020)

Second HPRA safety update on COVID-19 vaccines
Publicado: (2021)

New EMA/ECDC initiative for monitoring COVID-19 vaccines
Publicado: (2021)

HPRA safety update on BioNTech and Moderna COVID-19 vaccines
Publicado: (2021)

Safety update on COVID-19 vaccine Comirnaty finds no new concerns
Publicado: (2021)

EMA and ICMRA urge continuation of COVID-19 vaccine safety trials
Publicado: (2020)

PRAC meeting 5 August 2021: COVID-19 vaccine safety issues
Publicado: (2021)

COVID-19 vaccine errors dominate ISMP's list of top 10 safety concerns for 2021
Publicado: (2022)

COVID-19 vaccine and influenza vaccine mix-ups
Publicado: (2021)

No safety concerns with Comirnaty vaccine in pregnancy
Publicado: (2021)

EMA assessing safety of anakinra in adults with COVID-19
Publicado: (2021)

Antimalarial use in COVID-19 patients requires close monitoring
Publicado: (2020)

COVID-19 vaccination encouraged by the EMA/ECDC
Publicado: (2021)

Cutaneous vasculitis following COVID-19 vaccination
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021)

COVID-19 vaccination and risk of neuralgic amyotrophy
Publicado: (2022)

ISMP reports: errors or hazards with COVID-19 vaccines
Publicado: (2021)

Advice on COVID-19 vaccines approved in UK by MHRA
Publicado: (2021)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Falsified COVID-19 vaccine recently identified in Mexico
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Product monographs for COVID-19 vaccines updated in Canada
Publicado: (2021)

No association between COVID-19 vaccination and menstrual disorders
Publicado: (2021)

Janssen COVID-19 vaccine-related tinnitus and dizziness
Publicado: (2021)

PMDA: precautions should be revised for Covid-19 vaccine
Publicado: (2021)

Possibility of mix-up with paediatric COVID-19 vaccines
Publicado: (2021)

PRAC: blood clots with Janssen's COVID-19 vaccine
Publicado: (2021)

COVID-19 vaccination errors in USA reported to ISMP
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Signal for COVID-19 vaccine-related menstrual disorders
Publicado: (2022)

COVID-19 vaccine-induced VITT/TSS in Malaysia
Publicado: (2022)

Pfizer-BioNTech COVID-19 vaccine: AEs after vaccination in New Zealand
Publicado: (2021)

Phase III trial of Covid-19 treatment paused for safety concerns
Publicado: (2020)

No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine
Publicado: (2021)

Reports of flu-like symptoms after COVID-19 vaccination
Publicado: (2021)

COVID-19 vaccine AE reports in Australia and New Zealand
Publicado: (2021)

Vial and carton labelling updated for Moderna COVID-19 vaccine
Publicado: (2021)

Revisions of precautions for COVID-19 vaccines and other drugs in Japan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7sc6lqidqjl00bjqcto7rsjap0